carbamates has been researched along with scutellarin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Deng, Y; Li, Y; Liu, Q; Qiang, X; Sang, Z; Tan, Z; Xiao, G | 1 |
| Chen, J; Dai, Z; Fu, X; Li, H; Li, L; Li, Y; Liu, T; Luo, K; Wu, D; Zhao, Y | 1 |
2 other study(ies) available for carbamates and scutellarin
| Article | Year |
|---|---|
Multifunctional scutellarin-rivastigmine hybrids with cholinergic, antioxidant, biometal chelating and neuroprotective properties for the treatment of Alzheimer's disease.
Topics: Acetylcholinesterase; Alzheimer Disease; Animals; Antioxidants; Apigenin; Blood-Brain Barrier; Butyrylcholinesterase; Carbamates; Cell Line; Chelating Agents; Cholinesterase Inhibitors; Cognition; Glucuronates; Humans; Mice; Molecular Docking Simulation; Neuroprotective Agents; Rats | 2015 |
Design, synthesis and evaluation of novel scutellarin and scutellarein-N,N-bis-substituted carbamate-l-amino acid derivatives as potential multifunctional therapeutics for Alzheimer's disease.
Topics: Acetylcholinesterase; Alzheimer Disease; Amino Acids; Amyloid beta-Peptides; Animals; Antioxidants; Apigenin; Carbamates; Cholinesterase Inhibitors; Drug Design; Glucuronates; Mice; Neuroprotective Agents; Rats; Structure-Activity Relationship | 2022 |